HCLTech Q4FY26 miss: FY27 growth guide at 1–4%

What changed after HCLTech’s Q4FY26 update

HCL Technologies faced a sharp reset in investor expectations after reporting weaker-than-expected Q4FY26 numbers and issuing subdued guidance for FY27. The stock fell sharply on Wednesday, extending a sell-off that has now taken the decline to about 15% in just three sessions. The move came as brokerages pointed to misses across key metrics and reduced near-term visibility. Several firms cut target prices, and at least a few shifted ratings to more cautious stances. The immediate market reaction reflected concerns that the company’s recent growth premium over peers may be narrowing.

FY27 guidance: the headline numbers investors focused on

HCLTech guided for FY27 revenue growth of 1% to 4% year-on-year in constant currency at the company level. For services, the company guided 1.5% to 4.5% year-on-year in constant currency. Brokerages interpreted the range as signalling a cautious view on demand, particularly at the upper end. HDFC Institutional Equities, for instance, said the guidance suggests limited conviction at the top end. It added that the lower end assumes continued soft discretionary spending and that two troubled clients are ramping down beyond plan.

Why the stock corrected: weak exit and softer near-term visibility

HDFC Institutional Equities flagged a weak Q4 exit and said it sees continued weakness into 1QFY27. It also argued that HCLTech’s growth leadership is fading, which matters because that premium had been a key part of the stock’s re-rating. In the broader broker commentary, the theme was consistent: weaker forward visibility after the March-quarter performance and the FY27 outlook. Brokers also noted that subdued guidance tends to weigh on sentiment even when the longer-term narrative remains intact.

HDFC Institutional Equities: downgrade and a sharp target reset

HDFC Institutional Equities downgraded HCLTech to ‘ADD’ from ‘Buy’. It said it expects HCLTech to deliver at the midpoint of the FY27 guidance, given the weak Q4 exit and its view of continued weakness in 1QFY27. The brokerage cut its FY27 and FY28 estimates by 4% to 5%. It also reduced its valuation multiple, saying HCLTech’s growth premium over peers is diminishing, and cut its target multiple to 15 times from 18 times earlier.

HDFC Institutional Equities set a target price of Rs 1,160, down from its earlier target of Rs 1,465. The brokerage explicitly linked the downgrade to the FY27 growth range, the demand backdrop in discretionary spending, and the client-specific ramp-downs mentioned in its note.

Jefferies: among the most cautious calls after the guidance

Jefferies stood out as one of the most bearish voices in the set of reactions cited. It downgraded HCLTech to Underperform and assigned a price target of Rs 1,165, described as among the lowest on the Street in the coverage referenced. Jefferies said it expects HCLTech’s organic revenue growth in FY27 to be 2.4%, and cut its target price-to-earnings multiple from 18x to 16x. The framing from Jefferies centred on slower organic growth and valuation discipline in a softer demand environment.

Citi: neutral stance, but warning signs in forward indicators

Citi maintained a Neutral view but reduced its target price to Rs 1,385, calling the quarter “a weak 4Q” with revenues, deal TCV, and growth outlook below expectations. It highlighted deteriorating forward indicators, including TTM deal TCV up just 1% YoY and headcount growth of 1.7% YoY. Citi also cited management commentary on reduced discretionary spend in telecom and the discontinuation of two SAP programmes. It trimmed FY27–FY28 EPS estimates by 1% to 2%, warning that weak guidance could weigh on the stock in the near term.

Other broker actions: cuts across the board, but not all bearish

The broader Street reaction leaned cautious, with price targets cut by about 3% to 6% following the quarterly performance referenced. JPMorgan maintained a Neutral rating and lowered its target price to Rs 1,370 from Rs 1,419. HSBC retained a Hold rating and cut its target to Rs 1,480 from Rs 1,560.

Not all brokerages turned negative. CLSA retained Outperform with a target of Rs 1,519, even while acknowledging the quarter was disappointing across revenue, EBIT margins, the order book, and FY27 guidance. CLSA also flagged limited visibility on offsetting potential AI-driven revenue deflation through incremental volumes. Nomura maintained a Buy call and cited one of the higher targets mentioned, at about Rs 1,600.

Key broker calls and target changes at a glance

Market impact: what investors are weighing now

The sell-off suggests the market is repricing HCLTech for slower near-term growth and reduced conviction on discretionary spending. The FY27 guidance range, and broker commentary about a weak Q4 exit into 1QFY27, has made quarterly execution and deal conversion key swing factors for sentiment. Citi’s focus on deal TCV growth and headcount trends adds another layer to the near-term debate, because both are often used as indicators of demand and delivery capacity. At the same time, the spread in target prices shows that investors are still dividing the story into near-term uncertainty versus longer-term competitiveness.

Why this matters for the broader IT services sector

HCLTech’s guidance and the subsequent broker reset are being read as part of a wider caution across large-cap IT services on discretionary spending. Multiple brokers referenced reduced discretionary spend in telecom as an area of pressure. The discussion around potential AI deflation to revenues, and whether incremental volumes can compensate, also reflects an emerging theme in sector research. For investors, these inputs matter because they influence both near-term earnings expectations and valuation multiples.

Conclusion

HCLTech’s weak Q4FY26 exit and FY27 constant-currency growth guidance of 1% to 4% has triggered a rapid repricing, with the stock down about 15% in three sessions and multiple broker target cuts. The next data points that could influence sentiment are management’s follow-through on the FY27 range, early-quarter demand signals, and any improvement in forward indicators such as deal TCV and headcount trends.